![]() Pharvaris Pharvaris is a clinical-stage company focused on the discovery and development of oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. | ![]() Beijing Sun-Novo Pharmaceutical Research Beijing Sun-Novo Pharmaceutical Research (北京阳光诺和药物研究股份有限公司) is a company that specializes in the research and development of chemical and peptide drugs. | ||
Founding Date | Founding Date 2015 | Founding Date 1966 | Founding Date 2009 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Zug, CH HQ Leiden, NL Lexington, US | Locations CN HQ | |
Employees | Employees 108 | Employees 650 | Employees 1,556 |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) N/A | Valuation ($) 693.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥1.1b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥537.3m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥539.1m (FY, 2024) |
Net income | Net income (€175.7m) (FY, 2025) | Net income N/A | Net income ¥169m (FY, 2024) |
MDS Pharma Services is a provider of drug discovery and development solutions.
View company
Beijing Sun-Novo Pharmaceutical Research (北京阳光诺和药物研究股份有限公司) is a company that specializes in the research and development of chemical and peptide drugs.
View company